Cargando…
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination. Plasma spike (S)-specific immunoglobulins peak after one vaccine shot in individua...
Autores principales: | Lozano-Rodríguez, Roberto, Valentín-Quiroga, Jaime, Avendaño-Ortiz, José, Martín-Quirós, Alejandro, Pascual-Iglesias, Alejandro, Terrón-Arcos, Verónica, Montalbán-Hernández, Karla, Casalvilla-Dueñas, José Carlos, Bergón-Gutiérrez, Marta, Alcamí, José, García-Pérez, Javier, Cascajero, Almudena, García-Garrido, Miguel Ángel, Balzo-Castillo, Álvaro del, Peinado, María, Gómez, Laura, Llorente-Fernández, Irene, Martín-Miguel, Gema, Herrero-Benito, Carmen, Benito, José Miguel, Rallón, Norma, Vela-Olmo, Carmen, López-Morejón, Lissette, Cubillos-Zapata, Carolina, Aguirre, Luis A., Fresno, Carlos del, López-Collazo, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687760/ https://www.ncbi.nlm.nih.gov/pubmed/34986327 http://dx.doi.org/10.1016/j.celrep.2021.110235 |
Ejemplares similares
-
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2023) -
Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
por: Lozano‐Rodríguez, Roberto, et al.
Publicado: (2022) -
The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission
por: Avendaño‐Ortiz, José, et al.
Publicado: (2021) -
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2022) -
Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer
por: Montalbán-Hernández, Karla, et al.
Publicado: (2022)